High Rate of Deep Remission for Relapsed/Refractory CLL Using Triple Regimen.

Published Date: 29 Apr 2024

Over 90% of cases are undetectable, and ctDNA is promising for early recurrence detection.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New First-Line Option for Advanced ALK-Positive Lung Cancer

2.

An ultrasound breast patch with conformability might help with early breast cancer detection.

3.

CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma

4.

Team finds broken 'brake' on cancer mutation machine.

5.

ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot